Theravasc is a biotechnology company developing repurposed drugs for vascular disease markets.
Business Model:
Revenue: $13.9M
Employees: 51-200
Address: 10000 Cedar Ave
City: Cleveland
State: OH
Zip: 44106
Country: US
TheraVasc, Inc., a biotechnology company, develops repurposed drugs for vascular disease markets. It offers TV1001, an oral formulation of sodium nitrite that targets patient populations with poor blood flow to the extremities, such as those with diabetic leg and foot problems, and peripheral artery disease. The company was incorporated in 2009 and is based in Cleveland, Ohio.
Contact Phone:
+13183493851
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2016 | Venture Round | 1 | - |
Rev1 Ventures Rev1 Ventures |
9/2010 | Series A | 5 | $2.4M |
JumpStart North Coast Ventures Physicians Investment Group Portal Capital Rev1 Ventures JumpStart North Coast Ventures Physicians Investment Group Portal Capital Rev1 Ventures |
5/2013 | Equity | $172k | 3/2014 | Venture Round | $350k | 11/2013 | Venture Round | $172.5k | 1/2010 | Seed Round | 2 | $500k |
JumpStart Portal Capital JumpStart Portal Capital |
11/2016 | Venture Round | 1 | - |
Rev1 Ventures Rev1 Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|